Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Green Cross LabCell (144510 KS)
Watchlist
16
Analysis
Health Care
•
South Korea
Green Cross LabCell Corp. is a biotechnology company that researches and develops cell therapy products. The Company is also engaged in cell banking, clinical laboratory services, clinical trial, and bio-logistics services.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Green Cross Cell
•
10 Oct 2021 04:12
GC Lab Cell Merger: Multi-Staged Arb Setups for Swap Spreads & KOSDAQ 150 Rebalancing on Oct 27
GC Lab Cell merger's cancellation risk has gone as the stock purchase cost was kept below the threshold. This post examines the stock swap arb...
Sanghyun Park
Follow
502 Views
Share
bullish
•
Green Cross Cell
•
13 Sep 2021 11:59
Green Cross Merger Got Shareholder Approval (Both Companies): Arb Spread at 5%, I'd Trade It
Green Cross Merger got shareholder approval today from both companies. The current arb spread is at 5%. This post explains why I would arb-trade it...
Sanghyun Park
Follow
421 Views
Share
bearish
•
Green Cross LabCell
•
25 Aug 2021 14:08
Green Cross Stock Swap: A 5% Spread Is a Rare Opportunity
This post examines the Green Cross stock swap event, which is currently at a spread of 5% two weeks before the appraisal rights exercise period.
Sanghyun Park
Follow
344 Views
Share
bullish
•
Green Cross LabCell
•
20 Jul 2021 08:47
Green Cross Merger Swap Summary & Arb Spread Status
This merger swap is very similar to the recent case of the GS merger swap. So, we are likely to face a rather juicy swap spread opening probably 2...
Sanghyun Park
Follow
452 Views
Share
bearish
•
Green Cross Cell
•
19 Jul 2021 20:43
GC Cell - GC LabCell: Korean Biopharma Merger Trading Tight
South Korean Biopharma companies GC Cell and GC Lab Cell are merging in an all-stock Deal. The companies have a combined market cap of ~US$1.5bn....
Janaghan Jeyakumar, CFA
Follow
492 Views
Share
First
Previous
1
2
3
4
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x